An early adopter of the Innovative Licensing and Access Pathway (ILAP), Niche Science & Technology Ltd was the first CRO to submit a successful ILAP application.
We have the experience and understanding of the ILAP pathway to guide you in your submissions to the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).
ReCode Therapeutics is a US-based, clinical-stage genetic medicines company is developing therapeutics for genetically...
Erytech Pharma SA is a clinical-stage biopharmaceutical company based in Lyon, France, best known for its proprietary...
DemeRx is a US-based clinical stage pharmaceutical development company advancing drug candidates as therapies for...
Dummy text of the printing and typesetting industry. Lorem Ipsum
Telling a story is essential to any presentation and our team integrates technical artistic ability with a comprehensive understanding of medicine and science.
Clinical trials require the production and maintenance of a wide range of essential documents to ensure that the trial is conducted in a rigorous and ethical manner.
We tailor our services to fit your needs based on your scope of funding, organisation and the level of support you require. Our team can support all your writing needs.
The world's first human COVID challenge trial has been given the green light
The world's first human COVID challenge trial has been given the green light
Get our latest news and publications
Sign up to our news letterSocial
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom